The team has an Overweight rating on Novo stock with a price target of 1,050 Danish kroner ... prevalent in patients—will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback